For people taking an oral bisphosphonate for osteoporosis, the risk of a jaw complication called MRONJ after a tooth extraction is low, with most studies placing it under one percent. The risk is higher, in the range of a few percent up to much more, for people on high dose intravenous bone medication as part of cancer care. MRONJ stands for medication related osteonecrosis of the jaw, and while it is uncommon, it is worth understanding if you take one of these medications, because a little planning before dental work lowers the risk further.
Key takeaways
- MRONJ is a rare condition where an area of jawbone fails to heal and becomes exposed, usually after dental surgery.
- It is linked to bone medications such as bisphosphonates (for example alendronate) and denosumab, used for osteoporosis and some cancers.
- For osteoporosis doses taken by mouth, the risk after extraction is low, often under one percent, and rises with longer use.
- Do not stop your bone medication on your own. Always coordinate with your doctor and dentist.
- Good gum health and timing non urgent extractions sensibly are the best ways to reduce risk.
What MRONJ actually is
Bone is living tissue that constantly renews itself. Bisphosphonates and denosumab work by slowing the cells that break bone down, which is exactly what helps prevent osteoporotic fractures. In the jaw, that same slowing can occasionally make the bone less able to repair itself after an injury such as an extraction. When that happens, a small area of bone can stay exposed and fail to heal, which is MRONJ. It is defined as exposed jawbone, or bone that can be probed through the gum, that has been present for more than eight weeks in someone taking these medications who has not had radiotherapy to the jaw.
The one rule: never stop your medication on your own
The most important message is that these medications protect you from serious fractures, and the fracture risk of stopping them is usually far greater than the small jaw risk of continuing. Any decision about pausing a bone medication around dental surgery is one for your doctor and dentist together, never something to do alone. For osteoporosis patients the current view is that routine dental treatment, including most extractions, can usually go ahead with sensible precautions.
Who is at higher risk
Risk is not the same for everyone on these medications. The main factors are the type and dose, how long you have taken it, and whether other conditions affect healing.
| Situation | Relative MRONJ risk | Notes |
|---|---|---|
| Oral bisphosphonate, osteoporosis, under 4 years | Low | Routine extractions usually proceed with standard care |
| Oral bisphosphonate, over 4 years | Higher than the above | Risk rises with duration, especially with steroids |
| Denosumab, osteoporosis | Low but present | Effect wears off faster, so timing can be planned |
| High dose IV medication, cancer care | Considerably higher | Needs careful specialist coordination before surgery |
Smoking, diabetes, steroid use and active gum infection all add to the risk, which is why keeping the mouth healthy in the first place matters so much. Our guide to gum disease treatment explains how to keep the gums and supporting bone in good shape.
How dental work is planned around bone medication
The best approach is to get the mouth healthy before starting one of these medications where possible, so any teeth likely to need removal are dealt with first. If you are already taking the medication, the plan usually involves treating teeth conservatively where it is safe to do so, keeping any surgery as gentle as possible, and following healing closely. Where a tooth might be saved rather than removed, that route is often preferred, which is one reason our guide to root canal versus extraction is worth reading. After any extraction, the site is reviewed until it has healed over.
What this means for implants and other treatment
Dental implants are not automatically ruled out for people on osteoporosis doses, but they call for a careful discussion of risks and healing. The conversation is different again for anyone on high dose cancer medication. If you are weighing tooth replacement options, our guides to dental implants and implant versus bridge versus denture set out the alternatives, all of which should be discussed with your dentist in light of your medication.
Frequently asked questions
Should I stop my bisphosphonate before a tooth extraction?
Not on your own. For osteoporosis doses, most extractions go ahead without stopping the medication. Any pause is a decision your doctor and dentist make together, weighing your fracture risk.
How common is MRONJ really?
For people on oral bisphosphonates for osteoporosis, it is uncommon, with extraction studies often reporting well under one percent. It is more common with high dose intravenous medication used in cancer care.
What are the warning signs?
Exposed bone, a non healing socket, pain, swelling or a bad taste weeks after an extraction. Tell your dentist promptly if a site has not healed as expected.
Can I still get dental implants?
Possibly, on osteoporosis doses, after a careful risk discussion. It is generally avoided or approached very cautiously on high dose cancer medication.
Does denosumab carry the same risk?
It carries a similar type of risk, but its effect on bone wears off faster than bisphosphonates, which can make timing of dental surgery easier to plan with your doctor.
The takeaway
MRONJ is a rare but real consideration for anyone on bisphosphonates or denosumab, and the risk for osteoporosis patients having routine extractions is low. The safest path is to keep the mouth healthy, treat problems early, and plan any surgery jointly with your doctor and dentist rather than stopping medication alone. The team at Lumi Dental can coordinate your care and explain your options. See our current deals page or read about general dental care at our Melrose Park practice. This article is general information and not a substitute for personal dental or medical advice.
